ALEXANDRA HUDAK: Open Payments
NPI 1578186862 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,050 in 54 payments from 17 companies in 2025. Trend: 2023 $750 · 2024 $1,994 · 2025 $1,050
Food & beverage: $1,050
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $263 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $141 |
| Ardelyx, Inc. | 5 | $106 |
| QOL Medical, LLC | 3 | $76 |
| Janssen Biotech, Inc. | 4 | $73 |
| PFIZER INC. | 4 | $64 |
| Ipsen Biopharmaceuticals, Inc | 3 | $63 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| Gilead Sciences, Inc. | 2 | $43 |
| Celltrion USA Inc. | 2 | $33 |
Products named: RINVOQ, ENTYVIO, IBSRELA, Sucraid, TREMFYA, XELJANZ, IQIRVO, SKYRIZI.
Industry payments across VA — which companies pay providers there.
